Companies › Eisai Inc.

Eisai Inc.

Company Pharma & Medical Devices

Eisai Inc. is listed as a company in Pharma & Medical Devices. It has filed 7 comment letters on 6 proposed federal rules between 2025 and 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
7
Rules commented on
6
First letter
2025-09-16
Latest letter
2026-09-10
Agencies most often
Centers for Medicare & Medicaid Services (5); Drug Enforcement Administration (2)

Activity by year

20251
20266

Letters

2026

Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V

DEA-2026-1321Justice Department, Drug Enforcement Administration · filed 2026-09-10

Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V

DEA-2026-1321Justice Department, Drug Enforcement Administration · filed 2026-09-10

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-08

Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

CMS-2026-2344Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-01

Global Benchmark for Efficient Drug Pricing (GLOBE) Model

CMS-2025-1889Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25

Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

CMS-2025-1888Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25

2025

Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction

CMS-2025-0304Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-09-16